Education, Science, Technology, Innovation and Life
Open Access
Sign In
  1. Home
  2. Journals
  3. MEDS Clinical Medicine
  4. Vol 4, Issue 7, 2023

Clinical effect analysis of budesonide atomization inhalation in the treatment of neonatal pneumonia

Download as PDF

DOI: 10.23977/medsc.2023.040715 | Downloads: 12 | Views: 291

Author(s)

Wei Qian 1, Zhang Wei 1

Affiliation(s)

1 Department of Pediatrics, Affiliated Hospital of Hebei University, Baoding, Hebei, China

Corresponding Author

Zhang Wei

ABSTRACT

To analyze the clinical effect of budesonide atomization inhalation in the treatment of neonatal pneumonia. This study was carried out from January 2018 to January 2023. Thirty-six children with severe neonatal pneumonia who were treated in hospitals during this period were selected into the study scope, and were divided into reference group and experimental group according to the two-color ball method, with 18 children in each group. The reference group was treated with routine symptomatic treatment, and the experimental group was treated with budesonide atomization inhalation on the basis of routine symptomatic treatment. The treatment effect, clinical symptom disappearance time, serum inflammatory index and complication rate of the two groups were observed and compared. The therapeutic effect of the experimental group was significantly better than that of the reference group (P < 0.05). The disappearance time of clinical symptoms such as wheezing, cough, lung rales and dyspnea in the experimental group was shorter than that in the reference group (P < 0.05). Serum inflammatory indexes of children in experimental group were lower than those in reference group (P < 0.05). The incidence of complications in the experimental group was significantly lower than that in the reference group (P < 0.05). Budesonide aerosol inhalation therapy for neonatal pneumonia is not only helpful to reduce the degree of inflammation in children, accelerate the disappearance time of clinical symptoms, but also helpful to avoid complications such as heart failure and optimize the clinical treatment effect, which is worthy of clinical promotion.

KEYWORDS

Budesonide atomization inhalation; Newborns; Pneumonia; Application effect

CITE THIS PAPER

Wei Qian, Zhang Wei, Clinical effect analysis of budesonide atomization inhalation in the treatment of neonatal pneumonia. MEDS Clinical Medicine (2023) Vol. 4: 88-93. DOI: http://dx.doi.org/10.23977/medsc.2023.040715.

REFERENCES

[1] Zhuang Lili. Clinical analysis of ambroxol plus budesonide nebulized inhalation for neonatal pneumonia [J]. Health Food in China, 2023 (6): 184-186.
[2] Dong Ge, Zhu Xinfeng. Clinical effect of ambroxol hydrochloride and budesonide aerosol inhalation combined with continuous positive airway pressure ventilation in the treatment of neonatal pneumonia [J]. Clinical Medical Research and Practice, 2022, 7 (17): 122-124.
[3] Jiang Xiaoli, Liu Lei. Observation of the effect of budesonide with acetylcysteine solution in neonatal pneumonia [J]. Clinical Medicine, 2022, 42 (04): 112-113.
[4] Li Meiqing, Mao Huiying, Lai Jieyu, etc. Effect of ambroxol and budesonide on neonatal pneumonia [J]. Shenzhen Journal of Integrated Traditional Chinese and Western Medicine, 2022, 32 (05): 105-108.
[5] Yin Juanjuan. Clinical efficacy and safety evaluation of ambroxol combined with budesonide in neonatal pneumonia [J]. Contemporary Medicine, 2022, 28 (01): 13-15.
[6] Yang Xiaojing, Chen Ping, He Yating. Clinical study of ambroxol-assisted budesonide suspension for neonatal pneumonia [J]. Yunnan Medicine, 2022, 43 (04): 44-46.
[7] Qi Ling, Wei Li, Li Jing. Clinical study of piperacillin sodium and tazobactam sodium combined with budesonide aerosol inhalation for neonatal pneumonia [J]. Chinese Journal of Clinical Pharmacology, 2023, 39 (14): 1979-1982.
[8] Zhang Tingting. Analysis of the effects of budesonide aerosol inhalation combined with ambroxol in neonatal pneumonia [J]. Kang Yi, 2023 (12): 215-217.
[9] Song Shanshan. Study on the clinical effect of ambroxol + budesonide atomization therapy for neonatal pneumonia [J]. Chinese and Foreign Women's Health Research, 2023 (12): 6-7, 18.
[10] Yang Weili, Deng Yi, Yang Juanjuan, et al. Analysis of the progression of aerosol inhaled budesonide suspension for neonatal pneumonia [J]. Modern drug application in China, 2023, 17 (10): 170-172.
[11] Zhou Shu, Lu Lei, Guo Zhiyuan, et al. Meta-analysis based on the efficacy of ambroxol combined with budesonide aerosol inhalation on neonatal pneumonia [J]. Journal of Bengbu Medical College, 2022, 47 (2): 242-248.

Subscription
E-Mail Alert
Most popular papers
Call for Special Issue
Publication Ethics & OA Statement
Plagiarism Policy
Contact Us
Downloads: 4575
Visits: 198163

Sponsors, Associates, and Links

All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.